Spots Global Cancer Trial Database for Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
Official Title: A Multicenter Randomized Phase III, Double-blind Study Comparing Efficacy of the Association of Exemestane and Celecoxib Versus Exemestane and Placebo in Menopausal Patients With Metastatic Breast Cancer.
Study ID: NCT00525096
Conditions
Study Description
Brief Summary: To discover if the adding of a coxib increases the efficacy of the Aromasine.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Gilles FREYER, PhD
Affiliation: Centre Hospitalier Lyon Sud - France
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
